Your session is about to expire
← Back to Search
Vitamin K2
Low-Dose Vitamin K2 (45 mcg/d) for Insulin Resistance
N/A
Waitlist Available
Led By Norman K Pollock, Ph.D.
Research Sponsored by Augusta University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 8 to 17 years
BMI less than 85th percentile for age and gender
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Study Summary
This trial is testing whether vitamin K2 supplementation can improve carboxylation of osteocalcin and matrix Gla protein, and whether this can have an effect on markers associated with diabetes and cardiovascular disease risk.
Eligible Conditions
- Insulin Resistance
- Obesity
- Insulin Sensitivity
- Prediabetes
- High Cholesterol
- Diabetes
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Body Weight Changes
Change in insulin sensitivity
Change in serum lipid concentrations
Secondary outcome measures
Change in arterial stiffness (pulse wave velocity)
Change in coagulation
Change in endothelial function (Flow-mediated dilation)
+1 moreTrial Design
3Treatment groups
Active Control
Placebo Group
Group I: Low-Dose Vitamin K2 (45 mcg/d)Active Control1 Intervention
The low-dose vitamin K2 group will take one 45-mcg vitamin K2 softgel capsule and one placebo softgel capsule every day for 8 weeks.
Group II: High-Dose Vitamin K2 (90 mcg/d)Active Control1 Intervention
The high-dose vitamin K2 group will take one 90-mcg vitamin K2 softgel capsules every day for 8 weeks.
Group III: Placebo-ControlPlacebo Group1 Intervention
The placebo-control group will take one placebo softgel capsules every day for 8 weeks.
Find a Location
Who is running the clinical trial?
Yale UniversityOTHER
1,841 Previous Clinical Trials
2,734,497 Total Patients Enrolled
26 Trials studying Insulin Resistance
5,381 Patients Enrolled for Insulin Resistance
Tufts UniversityOTHER
260 Previous Clinical Trials
661,092 Total Patients Enrolled
5 Trials studying Insulin Resistance
290 Patients Enrolled for Insulin Resistance
Augusta UniversityLead Sponsor
210 Previous Clinical Trials
84,998 Total Patients Enrolled
2 Trials studying Insulin Resistance
60 Patients Enrolled for Insulin Resistance
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger